MedTrace Logo

ICARE-LCS QUERI Partnered Evaluation Initiative: Integrating Comprehensive Tobacco Treatment to Enhance Lung Cancer Screening

NCT06745258 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 7

Last updated 2026-02-20

No results posted yet for this study

Summary

Lung cancer is the leading cause of cancer-related death among Veterans with 90% of cases attributable to smoking. Lung cancer screening (LCS) combined with smoking cessation saves the most lives. ICARE-LCS seeks to decrease health inequality and improve Veteran health by reducing smoking rates among Veterans receiving LCS. ICARE-LCS will use implementation methods to inform national cancer prevention efforts and build infrastructure necessary to support broad implementation of high-impact tobacco dependence treatment (TDT) processes in LCS programs.

Conditions

  • Tobacco Dependence Treatment
  • Lung Cancer Screening

Interventions

OTHER

External Facilitation

Multi-component facilitation strategy to address identified implementation needs

Sponsors & Collaborators

  • VA Oncology and Precision Medicine

    collaborator UNKNOWN

  • VA Tobacco Use Treatment National Program Office

    collaborator UNKNOWN

  • VA National Center for Lung Cancer Screening

    collaborator UNKNOWN

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Anne C. Melzer, MD MS · Minneapolis VA Health Care System, Minneapolis, MN

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-01
Primary Completion
2027-06-30
Completion
2027-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06745258 on ClinicalTrials.gov